 |
 |

Immunization Levels Among Premature and Low-Birth-Weight Infants and Risk Factors for Delayed Up-to-Date Immunization Status
Robert L. Davis, MD, MPH;
David Rubanowice, BS;
Henry R. Shinefield, MD;
Ned Lewis, MPH;
David Gu, PhD;
Steven B. Black, MD;
Frank DeStefano, MD, MPH;
Paul Gargiullo, PhD;
John P. Mullooly, PhD;
Robert S. Thompson, MD;
Robert T. Chen, MD, MA;
for the Centers for Disease Control and Prevention Vaccine Safety Datalink Group
JAMA. 1999;282:547-553.
Context Studies have noted that health care professionals may not conform to proper immunization schedules for premature and low-birth-weight infants in the United States. Little is known about the success of current efforts to immunize these high-risk infants.
Objective To describe current immunization practices for premature and low-birth-weight infants and ascertain risk factors for poor immunization status, using large population-based data sources.
Design and Setting Cohort and case-control analyses of immunization data tracked from March 1991 through March 1997 for 3 large health maintenance organizations (HMOs) participating in the Centers for Disease Control and Prevention's Vaccine Safety Datalink project.
Participants A total of 11,580 low-birth-weight and premature infants were enrolled from birth to age 2 months; 6832 of these were continuously enrolled from birth to age 24 months. At age 2 months, there were 173,373 full-term, normal-birth-weight infants enrolled as controls; at age 24 months, there were 103,324.
Main Outcome Measures Age-specific immunization status by prematurity and birth weight (<1500 g, 1500-2500 g, born at <38 weeks' gestation with birth weight of >2500 g, or full-term with normal birth weight) and patient characteristics associated with up-to-date status.
Results At each age, infants weighing less than 1500 g at birth had lower up-to-date immunization levels than other infants. At age 6 months, 52% to 65% of infants weighing less than 1500 g were up-to-date at each of the 3 HMOs compared with 69% to 73% of those weighing 1500 to 2500 g, 66% to 80% of premature infants weighing more than 2500 g, and 65% to 76% of full-term, normal-birth-weight infants. By age 24 months, 78% to 86% of infants weighing less than 1500 g were up-to-date, significantly less than heavier infants, who had levels of 84% to 89%. Well-child preventive care strongly predicted immunization status, while concomitant pulmonary disease did not.
Conclusions Our data suggest that infants born prematurely are vaccinated at levels approaching that of the general population, but levels of vaccination for very low-birth-weight infants lag slightly behind.
Author Affiliations: Immunization Studies Program, Center for Health Studies (Drs Davis and Thompson and Mr Rubanowice), Department of Preventive Care (Dr Thompson), Group Health Cooperative of Puget Sound, Seattle, Wash; Departments of Pediatrics and Epidemiology, University of Washington Schools of Medicine and Public Health, Seattle (Dr Davis); Department of Research, Northern California Kaiser Permanente, Oakland, Calif (Drs Shinefield and Black and Mr Lewis); Department of Pediatrics, Emory University, Atlanta, Ga (Dr Gu); National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga (Drs DeStefano, Gargiullo, and Chen); and Northwest Kaiser Permanente, Portland, Ore (Dr Mullooly). A complete list of the members of the Centers for Disease Control and Prevention Vaccine Safety Datalink Group appears at the end of this article.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
August 11, 1999
JAMA. 1999;282(6):603-604.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Evaluation of Vaccine Coverage for Low Birth Weight Infants During the First Year of Life in a Large Managed Care Population
Batra et al.
Pediatrics 2009;123:951-958.
ABSTRACT
| FULL TEXT
Vaccination Coverage by Special Health Care Needs Status in Young Children
O'Connor and Bramlett
Pediatrics 2008;121:e768-e774.
ABSTRACT
| FULL TEXT
Antipolyribosyl Ribitol Phosphate Response of Premature Infants to Primary and Booster Vaccination With a Combined Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio Virus/Haemophilus influenzae Type b Vaccine
Omenaca et al.
Pediatrics 2007;119:e179-e185.
ABSTRACT
| FULL TEXT
Immunisation of premature infants
Bonhoeffer et al.
Arch. Dis. Child. 2006;91:929-935.
ABSTRACT
| FULL TEXT
The Immunologic Basis for Neonatal Immunizations
Baley and Leonard
NeoReviews 2005;6:e463-e470.
FULL TEXT
Safety of Thimerosal-Containing Vaccines: A Two-Phased Study of Computerized Health Maintenance Organization Databases
Verstraeten et al.
Pediatrics 2003;112:1039-1048.
ABSTRACT
| FULL TEXT
Immunization of Preterm and Low Birth Weight Infants
Saari and and Committee on Infectious Diseases
Pediatrics 2003;112:193-198.
ABSTRACT
| FULL TEXT
Delays in Receipt of Immunizations in Low-Birth-Weight Children: A Nationally Representative Sample
Langkamp et al.
Arch Pediatr Adolesc Med 2001;155:167-172.
ABSTRACT
| FULL TEXT
|